From the browser to the back end, the ‘boring’ choice is exciting again. We look at three trends converging to bring SQL back ...

The thick client is making a comeback. Here’s how next-generation local databases like PGlite and RxDB are bringing ...

Fabien Deshayes discusses the strategies behind Monzo’s Developer Velocity squad. He explains the "Platform as a Product" mindset, emphasizing the need for engineers with product acumen and tenure. He ...

Just like algae blooms in the ocean and pollen in the spring, there’s been an explosion in the past year or two of new software, related tools and lingo from the IT and mainstream/consumer side. Some ...

Druid AI CEO Joe Kim weighs in on why the future of enterprise agents needs a governance-first mindset that supports composability and extensibility.

Gambling content 21+. The New York Post may receive an affiliate commission if you sign up through our links. Read our editorial standards for more information. And then there were eight. Saturday’s ...

On Monday, Anthropic announced a new tool called Cowork, designed as a more accessible version of Claude Code. Built into the Claude Desktop app, the new tool lets users designate a specific folder ...

Cybersecurity researchers have discovered a new variant of a macOS information stealer called MacSync that's delivered by means of a digitally signed, notarized Swift application masquerading as a ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

ULANQAB, China—The U.S. invented the most powerful artificial-intelligence models and controls access to the most advanced computer chips, but China has an ace to play in the global AI contest. China ...

The new research provides evidence that Covid reinfections can increase the risk of long-term health consequences. By Pam Belluck Pam Belluck has covered long Covid since the condition first emerged.

With a mega investment of 6.5 billion dollars, Eli Lilly and Company has plans to develop a next-generation synthetic medicine active pharmaceutical product facility in Texas, USA. The facility will ...